InvestorsHub Logo
Followers 36
Posts 4276
Boards Moderated 1
Alias Born 11/03/2015

Re: None

Thursday, 10/19/2017 4:55:46 PM

Thursday, October 19, 2017 4:55:46 PM

Post# of 2139
Item 8.01 4:02 PM Other Events

On October 19, 2017, ContraVir Pharmaceuticals, Inc. issued a press release announcing it has dosed its first patient in the IND opening, Phase 1 study of tenofovir exalidex (TXL™) in renally-impaired patients.

The press release is attached as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99.1

ContraVir Pharmaceuticals, Inc. Press Release dated October 19, 2017

https://ih.advfn.com/p.php?pid=nmona&article=75900877

If you are going to panic,then you need to panic quickly.
Panda Lun Lun gave birth to her second set of twins on September 3!
Live Baby Panda Cam
http://www.zooatlanta.org/1212/panda_cam

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HEPA News